WHO grade II and III meningiomas: a study of prognostic factors.
about
Management of intracranial meningiomas in Enugu, NigeriaPreoperative radiologic classification of convexity meningioma to predict the survival and aggressive meningioma behavior.Prognostic factors for survival in patients with high-grade meningioma and recurrence-risk stratification for application of radiotherapy.Caspase-3 and survivin expression in primary atypical and malignant meningiomasDouble trouble: a tale of two radio-treatments.Pediatric meningiomas in The Netherlands 1974-2010: a descriptive epidemiological case study.Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningiomaExpression of c-MET in Invasive MeningiomaA prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.Meningiomas with Rhabdoid or Papillary Components : Prognosis and Comparison with Anaplastic Meningiomas.Relation of apparent diffusion coefficient with Ki-67 proliferation index in meningiomas.Anatomic location is a risk factor for atypical and malignant meningiomas.A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.Pediatric microcystic meningioma: a clinical, histological, and radiographic case-based review.Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases.Patterns of relapse and growth kinetics of surgery- and radiation-refractory meningiomas.Recurrent meningioma with malignant transformation: a case report and literature review.Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology.Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma.Atypical and anaplastic meningioma: outcomes in a population based study.Checkpoint inhibition in meningiomas.Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institution.Cytotoxic effects of statins and thiazolidinediones on meningioma cells.World Health Organization grade II meningiomas.Multimodal optical analysis of meningioma and comparison with histopathology.Extent of resection and overall survival for patients with atypical and malignant meningioma.World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment.The Role of Adjuvant Treatment in Patients with High-Grade MeningiomaReview of Current Evidence Regarding Surgery in Elderly Patients with Meningioma.Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutationsPIK3CA mutations in meningioma.The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells.Early postoperative radiotherapy improves progression free survival in patients with grade 2 meningioma.Epidemiology of meningioma in the United Kingdom.uPA/PAI-1 expression and uPA promoter methylation in meningiomas.Prediction of high-grade meningioma by preoperative MRI assessment.Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas.Survival benefit of postoperative radiation in papillary meningioma: Analysis of the National Cancer Data Base.The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?
P2860
Q30574316-7A2B191B-30C0-49ED-98B9-FEB43C9C88BAQ30912220-30AD8B7B-89B1-4112-B8EE-DD7F6F2FB914Q33599285-888600E6-C0A0-426C-B007-3926F4C18F77Q33771661-1022E08E-92D2-498F-9839-85EBD8006ED8Q34220119-E14F1100-4FBE-49F3-826A-D0A5FAB954B6Q34250513-0EF2ACD0-182D-4E0F-B0FB-06F4497404F3Q34359681-0DF2EF34-4896-4D4F-9193-27E4FE15DE31Q35170717-81AA12E2-9D16-4FC3-BD29-695F6D8D73D3Q36493847-38E7DF88-B7AD-4960-AABD-A3188770CC74Q37112567-79F0800F-A34C-4952-971A-1503831F33F2Q37177786-AE50BF7D-0643-448F-90F2-BDD3548EDB0DQ37226853-879CDF55-16EA-4728-B2F2-A804AA437C97Q37581072-993BFD8C-97C2-4164-920F-8DD48A21A4FFQ38068323-34657589-85F1-485B-B855-DB09626696B3Q38074045-3274DF8D-3910-429D-86A5-095552AC33E7Q38430591-29292239-5D64-4E0A-9AF0-028EA3BFBBE1Q38656468-852880D6-C28C-470B-A47B-AF3F714439B0Q38711744-A19B936E-E99E-4173-A4A1-41403B6C8FE7Q38771012-AF16ED1C-861E-4CA6-9535-85F54DB3560CQ38827423-4DB33CC6-0B00-4F13-80F4-E725248E965EQ38838646-6462C31F-B92B-45F8-A019-FA38918F8669Q39172845-D7823E05-EC22-4E26-81CD-44FAAB0F2694Q39661946-F0B4A8F6-8267-4FE1-9881-A43DB5A3ECCDQ39884623-C5ED516F-937C-493A-9475-0A2511FC6A50Q40001620-FA1C559C-600C-4E22-BF04-89FE9D04EAD1Q40606004-DA895A9A-91C0-4EFB-BBAB-47E291B4BE24Q40812108-C3586B3A-51EA-4535-AF36-971C3DF75A65Q41271334-0744E483-1858-4253-97A3-519AF2302337Q42257960-36F4F295-E906-4CF2-8272-25A45D125A64Q42548316-4FF3D5C6-F3DB-49E9-8479-EC7A0974A0E5Q42908544-0D062C34-6C55-4E19-AAB8-2553FAFB044EQ42927241-3DFA3365-87A0-47B4-8530-2D235B2F00A3Q43432933-AE42AE2F-FA4F-4814-B415-AB4DFB28A0B6Q43870265-A6D0D4E4-BCD0-480A-B137-19A65E2E9B31Q43951136-47D3E6C9-210D-4DEB-B480-7AB4436DD302Q44839894-3D1E213B-8FA6-4BD5-86F6-441F41C40FBDQ46449538-45CCB368-8059-4647-B164-B0572E9072E7Q46649981-C0B8BA3A-2702-4D54-A7B4-E359AFACFB5EQ47621240-20A42EFD-2F99-4860-A70B-4000721C5A34Q47758126-5E6AB45C-E16A-470A-A3D8-46A3596DBD94
P2860
WHO grade II and III meningiomas: a study of prognostic factors.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
WHO grade II and III meningiomas: a study of prognostic factors.
@en
WHO grade II and III meningiomas: a study of prognostic factors.
@nl
type
label
WHO grade II and III meningiomas: a study of prognostic factors.
@en
WHO grade II and III meningiomas: a study of prognostic factors.
@nl
prefLabel
WHO grade II and III meningiomas: a study of prognostic factors.
@en
WHO grade II and III meningiomas: a study of prognostic factors.
@nl
P2093
P2860
P1476
WHO grade II and III meningiomas: a study of prognostic factors
@en
P2093
Anne Durand
Anne Jouvet
Jacques Guyotat
Jean Jacques Moreau
Luc Bauchet
Michel Kalamaridès
Michelle Fèvre-Montange
Robert Deruty
P2860
P2888
P304
P356
10.1007/S11060-009-9934-0
P577
2009-06-27T00:00:00Z